Revostmm-4-4-2012 Ingles Maquetaciûn 1
Total Page:16
File Type:pdf, Size:1020Kb
Our cover SUMMARY Vol. 4 - Nº 4 - November-December 2012 Angiogenic endothe- lial cells from the umbilical vein (HUVEC) 105 EDITORIAL Authors: Sclerostin and bone in diabetes mellitus type 2 Raquel Santiago Jódar Gimeno E Mora, Antonio Casado Díaz, y José Manuel ORIGINALS Quesada 109 Variables which influence concentra- tions of sclerostin in patients with dia- betes mellitus type 2 and its association with bone metabolism García‐Martín A, Reyes‐García R, Rozas‐ Director Moreno P, Varsavsky M, Luque‐Fernández I, Manuel Sosa Henríquez Avilés‐Pérez MD, Muñoz‐Torres M Editor Head Mª Jesús Gómez de Tejada Romero Osteogenic effects of PTHrP (107-111) 117 loaded in bioceramics in a model of bone regeneration after a cavitary Sociedad Española de Investigación Ósea defect in the femur of a rabbit y del Metabolismo Mineral (SEIOMM) Lozano D, Trejo CG, Manzano M, Doadrio JC, President Salinas AJ, Dapía S, Caeiro Rey JR, Gómez‐ Javier del Pino Montes Barrena E, Vallet‐Regí M, García‐Honduvilla Vice-president N, Buján J, Esbrit P Josep Blanch Rubio Osteointegration and biocompatibility in Secretariat 127 vivo Mª Jesús Moro Álvarez of bio-inspired silicon carbide cera- mics in an experimental model in rabbits Treasure Guede D, Pereiro I, Solla E, Serra J, López‐ Carmen Valero Díaz de Lamadrid Peña M, Muñoz F, González‐Cantalapiedra Paseo de la Castellana, 135 (7ª planta) A, Caeiro JR, González P 28046 Madrid Telf: +34-917906834 133 Expression of RANKL and OPG in pri- Fax: +34-917906869 mary osteoblasts Delgado‐Calle J, Sañudo C, Sumillera M, e-mail: [email protected] Garcés CM, Riancho JA http://www.seiomm.org CLINICAL NOTES 141 Bone metastases and cord compresion Edición debut as follicular thyroid carcinoma Civantos Modino S, Navea Aguilera C, Avda. Reina Victoria, 47 (6º D) Pavón de Paz I, Almodovar Ruiz F, Elviro 28003 Madrid Peña MR Telf./Fax +34-915 538 297 e-mail: [email protected] 145 Costal right metastasis of prostate ade- http://www.ibanezyplaza.com nocarcinoma Espasa Font L, Supervía A, Del Baño F, Graphic design Concha García García Sarbu MI English translation Hypercalcemia crisis due to complex Andrew Stephens 149 parathyroid tumour: a diagnostic and Impresion surgical dilemma Imprenta Narcea Ovejero Gómez VJ, Díez Muñiz‐Alique M, Valid Support Díez Lizuaín ML, Pérez Martín A, 32/09-R-CM Azcarretazábal González‐Ontaneda T, Ingelmo Setien A Legal Deposit AS-4777-09 ISSN 1889-836X Submit originals: [email protected] On-line version: http://www.revistadeosteoporosisymetabolismomineral.com COMMITTEES / Rev Osteoporos Metab Miner 2012 4;4:x-x 103 Editorial Committee Committee of experts Pilar Aguado Acín Fernando Lecanda Cordero Javier Alegre López Pau Lluch Mezquida Teresita Bellido, Ph.D. María José Amérigo García José Andrés López-Herce Cid Department of Medicine, Division of Abdón Arbelo Rodríguez Mª Luisa Mariñoso Barba Endocrinology. Indiana University School of Miguel Arias Paciencia Guillermo Martínez Díaz-Guerra Medicine. Indianapolis, Indiana. Estados Unidos Emilia Aznar Villacampa María Elena Martínez Rodríguez Ernesto Canalis. MD, PhD Chesús Beltrán Audera Julio Medina Luezas St Francis Hospital and Medical Center, Hartford, Pere Benito Ruiz Leonardo Mellivobsky Saldier Connecticut. University of Connecticut. School of Santiago Benito Urbina Manuel Mesa Ramos Medicine, Farmington, Connecticut. Estados Unidos Miguel Bernard Pineda Pedro Mezquita Raya Pedro Betancor León Ana Monegal Brancos Patricia Clark Peralta. MD, PhD Josep Blanch i Rubió Josefa Montoya García Facultad de Medicina, UNAM. Unidad Clínica José Antonio Blázquez Cabrera María Jesús Moro Álvarez Epidemiológica. Hospital Infantil Federico Gómez. José Ramón Caeiro Rey Manuel Muñoz Torres México DF. México Javier Calvo Catalá Laura Navarro Casado Dr. Javier del Pino Montes Mª Jesús Cancelo Hidalgo Manuel Naves García Departamento de Medicina. Universidad de Jorge Cannata Andía José Luis Neyro Bilbao Salamanca. Sección de Reumatología. Hospital Antonio Cano Sánchez Xavier Nogués i Solán Universitario de Salamanca. Salamanca. España Cristina Carbonell Abella Joan Miquel Nolla Solé Jordi Carbonell Abelló José Antonio Olmos Martínez Dr. Manuel Díaz Curiel Pedro Carpintero Benítez Norberto Ortego Centeno Universidad Autónoma de Madrid. Unidad de Enrique Casado Burgos Santiago Palacios Gil-Antuñano Metabolismo Óseo. Hospital Fundación Jiménez Díaz. Santos Castañeda Sanz Esteban Pérez Alonso Instituto de Investigación FJD. Fundación Hispana de Fidencio Cons Molina Ramón Pérez Cano Osteoporosis y Metabolismo Mineral (FHOEMO). Sonia Dapia Robleda José Luis Pérez Castrillón Madrid. España Bernardino Díaz López Luis Pérez Edo Dr. Adolfo Díez Pérez Casimira Domínguez Cabrera Pilar Peris Bernal Universidad de Barcelona. Servicio de Medicina Anna Enjuanes Guardiola Concepción de la Piedra Gordo Interna. Instituto Municipal de Investigación Pedro Esbrit Argüelles José Manuel Quesada Gómez Médica. (IMIM). Hospital del Mar. Barcelona. Fernando Escobar Jiménez Enrique Raya Álvarez España José Filgueira Rubio Rebeca Reyes García Dr. Oswaldo Daniel Messina Jordi Fiter Areste José Antonio Riancho Moral Facultad de Medicina. Universidad de Buenos Juan José García Borrás Luis de Rio Barquero Aires. Hospital Cosme Argerich. Buenos Aires. Juan Alberto García Vadillo Luis Rodríguez Arboleya Argentina Eduardo Girona Quesada Minerva Rodríguez García Carlos Gómez Alonso Antonia Rodríguez Hernández Dra. María Jesús Gómez de Tejada Romero Milagros González Béjar Manuel Rodríguez Pérez (Editor Head) Jesús González Macías Montaña Román García Universidad de Sevilla. Departamento de Medicina. Emilio González Reimers Inmaculada Ros Villamajó Sevilla. España Jenaro Graña Gil Rafael Sánchez Borrego Dr. Manuel Sosa Henríquez Silvana di Gregorio Armando Torres Ramírez (Director) Daniel Grinberg Vaisman Antonio Torrijos Eslava Universidad de Las Palmas de Gran Canaria. Grupo Nuria Guañabens Gay Carmen Valdés y Llorca de Investigación en Osteoporosis y Metabolismo Roberto Güerri Fernández Carmen Valero Díaz de Lamadrid Mineral. Hospital Universitario Insular. Servicio de Federico Hawkins Carranza Ana Weruaga Rey Medicina Interna. Unidad Metabólica Ósea. Las Diego Hernández Hernández Jaime Zubieta Tabernero Palmas de Gran Canaria. España José Luis Hernández Hernández METHODOLOGY AND DESIGN OF DATA Gabriel Herrero-Beaumont Cuenca Pedro Saavedra Santana Esteban Jódar Gimeno José María Limiñana Cañal Volume 4 reviewers (2012) Bernardino Díaz López José Antonio Blázquez Cabrera Mª Jesús Gómez de Tejada Romero José Luis Hernández Hernández José Antonio Riancho Moral Xavier Nogués i Solán Juan José García Borrás José Luis Pérez Castrillón Jenaro Graña Gil Federico Hawkins Carranza Ana Monegal Brancós Pau Lluch Mezquida Manuel Mesa Ramos Manuel Naves Díaz Carlos Gómez Alonso Norberto Ortego Centeno Daniel Grinberg Vaisman Diego Hernández Hernández Javier del Pino Montes Ana Weruaga Rey Silvana di Gregorio Enrique Casado Burgos Laura Navarro Casado Minerva Rodríguez García Mª Luisa Mariñoso Barba Jordi Carbonell Abelló Rebeca Reyes García Sonia Dapia Robleda José Luis Neyro Bilbao Esteban Pérez Alonso Beatriz González López de Valcárcel Mª Jesús Cancelo Hidalgo Ernesto Cannalis Pedro Saavedra Santana Guillermo Martínez-Díaz Guerra Ramón Pérez Cano Manuel Sosa Henríquez Pilar Peris Bernal Roberto Carlos Güerri Fernández Mario Vicente Barrero Manuel Sosa Henríquez Gabriel Herrero-Beaumont Cuenca The Board of Directors and Management SEIOMM Magazine thanks you for your invaluable assistance. EDITORIAL / Rev Osteoporos Metab Miner 2012 4;4:105-106 105 Sclerostin and bone in diabetes mellitus type 2 Jódar Gimeno E Jefe del Servicio de Endocrinología y Nutrición Clínica - Hospital Universitario Quirón - Madrid Correspondence: Esteban Jódar Gimeno - Hospital Universitario Quirón - C/Diego de Velázquez, 1 - 28223 Pozuelo de Alarcón - Madrid (Spain) e-mail: [email protected] n the current number, García-Martín et the skeleton has been shown to have new and al.1 from the working group of Dr. unexpected functions in relation to the rest of the Muñoz of Granada report that blood organism. We have assisted in this process in the levels of sclerostin – the protein coded discovery and characterisation of fibroblast growth for by the gene SOST, which inhibits the factor 23 (FGF23), basically produced by the oste- osteoblast Wnt pathway - depend on the ocytes, not only as a phosphaturic factor, but also I sex, the age and the renal function of a hormone originating in the bone-inhibiting cal- patients with diabetes mellitus type 2 ciotropic hormones – PTH and D-4 hormone. (DM2). They also demonstrate, contrary to expec- Among these new functions is emerging the role tations, a negative relationship with the markers of bone tissue in the control of energy metabolism for bone remodelling, and a positive relationship which happens through the secretion of osteocal- with bone mineral density (BMD). Finally, they cin (BGP), which we should also consider to be a show that blood levels of sclerostin are lower in hormone produced by osteoblasts, which regula- patients with DM2 and osteoporosis irrespective tes the secretion of insulin, sensitiveness to insu- of the presence or absence of fractures. lin and the use of energy. The signalling pathway DM2 is a disease of high prevalence – up to 12- for insulin in the osteoblasts (OB) drives glucose 15% of the adult population in our country2 - and homeostasis in the body, the negative regulation with an enormous impact on